PregnancyBEARH2025NCT07524764
Female Reproductive Health in Canadian Armed Forces
An observational study of Pregnancy and Pelvic Floor Dysfunction, run by Université de Sherbrooke at 1 site in Canada.
Trial summary
This is a mixed-method study aimed at gathering new evidence on reproductive health among female service members in the Canadian Armed Forces (CAF). Reproductive health includes four primary domains: contraception; undesired reproductive outcomes (including unintended pregnancy, adverse pregnancy outcomes, and… Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pregnancy, Pelvic Floor Dysfunction, Military Personnel
- How many people
- 1,121 participants
- Where
- 1 siteCanada
- Study dates
- 19 May 2026to 15 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: All female individuals serving in the CAF and Veterans will be included in part 1. Part 2 will include female individuals having experienced a reproductive health issue while serving in the CAF. Part 3 will include clinicians, stakeholders and policymakers who care for or support reproductive health of female CAF members (active duty and Veterans).
Who may be able to join
- Female (biological sex)
- Aged at least 18 years old
- Completed Basic Military Qualification (including Regular Forces, Reserve Forces (Class A, B, or C), Canadian Rangers, COATS instructors, and survivors of the LGBT Purge whose official records of service have been changed to reflect the nature of their discharge)
- Female (biological sex)
- Aged at least 18 years old
- Completed Basic Military Qualification (including Regular Forces, Reserve Forces (Class A, B, or C), Canadian Rangers, COATS instructors, and survivors of the LGBT Purge whose official records of service have been changed to reflect the nature of their discharge)
Show all 10Show fewer
- Have experienced a reproductive health issue while serving in the CAF
- Healthcare providers (CAF Health Services, public servant, civilian) who has treated female patients who are actively serving and/or Veterans of the CAF in the past 5 years.
- Stakeholders who are involved in supporting reproductive health of female members of the CAF and/or Veterans.
- Policymakers who are involved in supporting reproductive health of female members of the CAF and/or Veterans.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site, 1 recruiting
- Recruiting
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4
Chris M Edwards, PhD, 1-888-463-1835 ext. 18439, labo.santepelvienne@USherbrooke.ca
Camille Simard, MSc, 1-819-821-8000 ext. 18439, labomorin@usherbrooke.ca
About this study
Official title: Female Reproductive Health in Canadian Armed Forces: Experience, Access to Care, and Support
This is a mixed-method study aimed at gathering new evidence on reproductive health among female service members in the Canadian Armed Forces (CAF). Reproductive health includes four primary domains: contraception; undesired reproductive outcomes (including unintended pregnancy, adverse pregnancy outcomes, and infertility); assisted reproductive care; and pelvic floor dysfunctions. Additional factors that may influence reproductive outcomes will also be explored, including gynecological health (including but not limited to menstrual health, menopause, breast injury, sexually transmitted and blood-borne infections) as well as physical and psychological health (including but not limited to repetitive strain injuries, depression, and post-traumatic stress disorder). Evidence gathered on reproductive health issues will include, but not limited to, the lived experiences (occurrence), associated risk factors, access to care, including barriers and facilitators, service utilization, and career-related impacts among actively serving members and Veterans of the CAF. These will inform the development of recommendations and support services aimed at improving reproductive health care within the CAF. This project is divided into 3 convergent parts:
Part 1: An online pan-Canadian survey that will achieve a minimum total sample of 1067 participants.
Read more
Part 2: Semi-structured individual interviews (open-ended questions) will be conducted with female CAF members and Veterans who have experienced at least one reproductive health issues. A total of 30 participants are estimated to be required to achieve data saturation across the four primary domains.
Part 3: Semi-structured group discussion (open-ended questions) will be conducted with healthcare providers, who have experience with treating female reproductive health issues in CAF members, as well as stakeholders and policymakers involved in supporting female members of the CAF/Veterans. A total of 24 healthcare providers/stakeholders/policymakers will form 3 group discussion (8 participants/group).
For all 3 parts, efforts in recruitment will be made to ensure representation across CAF elements, minority groups, and native language (French and English).
- Conditions
- Pregnancy, Pelvic Floor Dysfunction, Military Personnel, Contraception, Infertility, Women's Health
- Keywords
- Reproductive health issue, Women's health, Pregnancy, Infertility, Pelvic floor dysfunction, Contraception, Canadian Armed Forces, Military personnel
- Medical subject headings
- Infertility
What is being measured
The primary outcome is the main question the study is designed to answer.
Occurrence of female reproductive health issues
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options
Measured: Baseline
Lived experiences of female reproductive health issues
Assessed using semi-structured individual interviews with open-ended questions
Measured: Baseline
Risk factors of reproductive health issues
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions
Measured: Baseline
Barriers to access to care for reproductive health issues
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions and group discussion (open-ended questions) with healthcare providers, stakeholders and policymakers
Measured: Baseline
Facilitators to access to care for reproductive health issues
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions and group discussion (open-ended questions) with healthcare providers, stakeholders and policymakers
Measured: Baseline
Service utilization for reproductive health issues
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions and group discussion (open-ended questions) with healthcare providers, stakeholders and policymakers
Measured: Baseline
Career-related impact of reproductive health issues of female serving in the CAF
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions
Measured: Baseline
Recommendations and support services for improving female reproductive care within the CAF
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions and group discussion (open-ended questions) with healthcare providers, stakeholders and policymakers
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2026
- Study start19 May 2026
- Primary completion15 Dec 2026 (estimated)
- Study completion15 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PregnancyStudies of the same condition, open and under way.
- More trials run by Université de SherbrookeThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,121 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Université de Sherbrooke
- Sponsor type
- University, hospital or other
- Collaborators
- Veterans Affairs Canada, Canadian Armed Forces
- Responsible party
- Principal investigator, Mélanie Morin, Université de Sherbrooke
- Investigators
- Mélanie Morin, PhD, Principal investigator, PT, PhD, Full professor, Researcher, Director of the Pelvic Health Research Laboratory, Canada Research Chair in Women's pelvic health, Faculty of Medicine and Health Sciences, University of Sherbrooke and Research Centre of the CHUS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07524764
- Sponsor's protocol ID
- 2026-6177
- Acronym
- BEARH2025
- Status last verified
- May 2026
- First submitted
- 1 Apr 2026
- Last updated
- 22 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Due to the nature of the participant population (active-duty military personnel and Veterans) and confidential information, individual data will not be shared. Only deanonymized and aggregated data will be shared with the scientific population and/or other organizations, upon request.
Study at a glance
From the registry record, last updated by the sponsor on 22 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Female Reproductive Health in Canadian Armed Forces: Experience, Access to Care, and Support
- ClinicalTrials.gov ID
- NCT07524764
- Acronym / sponsor ID
- BEARH2025 / 2026-6177
- Conditions
- Pregnancy, Pelvic Floor Dysfunction, Military Personnel, Contraception, Infertility, Women's Health
- Keywords
- Reproductive health issue, Women's health, Pregnancy, Infertility, Pelvic floor dysfunction, Contraception, Canadian Armed Forces, Military personnel
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,121 participants (estimated)
- Lead sponsor
- Université de SherbrookeUniversity, hospital or other
- Collaborators
- Veterans Affairs Canada, Canadian Armed Forces
- Study start
- 19 May 2026 (actual)
- Primary completion
- 15 Dec 2026 (estimated)
- Study completion
- 15 Dec 2026 (estimated)
- First posted
- 13 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a mixed-method study aimed at gathering new evidence on reproductive health among female service members in the Canadian Armed Forces (CAF). Reproductive health includes four primary domains: contraception; undesired reproductive outcomes (including unintended pregnancy, adverse pregnancy outcomes, and infertility); assisted reproductive care; and pelvic floor dysfunctions. Additional factors that may influence reproductive outcomes will also be explored, including gynecological health (including but not limited to menstrual health, menopause, breast injury, sexually transmitted and blood-borne infections) as well as physical and psychological health (including but not limited to repetitive strain injuries, depression, and post-traumatic stress disorder). Evidence gathered on reproductive health issues will include, but not limited to, the lived experiences (occurrence), associated risk factors, access to care, including barriers and facilitators, service utilization, and career-related impacts among actively serving members and Veterans of the CAF. These will inform the development of recommendations and support services aimed at improving reproductive health care within the CAF. This project is divided into 3 convergent parts:
Part 1: An online pan-Canadian survey that will achieve a minimum total sample of 1067 participants.
Part 2: Semi-structured individual interviews (open-ended questions) will be conducted with female CAF members and Veterans who have experienced at least one reproductive health issues. A total of 30 participants are estimated to be required to achieve data saturation across the four primary domains.
Part 3: Semi-structured group discussion (open-ended questions) will be conducted with healthcare providers, who have experience with treating female reproductive health issues in CAF members, as well as stakeholders and policymakers involved in supporting female members of the CAF/Veterans. A total of 24 healthcare providers/stakeholders/policymakers will form 3 group discussion (8 participants/group).
For all 3 parts, efforts in recruitment will be made to ensure representation across CAF elements, minority groups, and native language (French and English).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- All female individuals serving in the CAF and Veterans will be included in part 1. Part 2 will include female individuals having experienced a reproductive health issue while serving in the CAF. Part 3 will include clinicians, stakeholders and policymakers who care for or support reproductive health of female CAF members (active duty and Veterans).
Key inclusion criteria (10 listed)
- Female (biological sex)
- Aged at least 18 years old
- Completed Basic Military Qualification (including Regular Forces, Reserve Forces (Class A, B, or C), Canadian Rangers, COATS instructors, and survivors of the LGBT Purge whose official records of service have been changed to reflect the nature of their discharge)
- Female (biological sex)
- Aged at least 18 years old
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Occurrence of female reproductive health issues
Time frame: Baseline
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options
Lived experiences of female reproductive health issues
Time frame: Baseline
Assessed using semi-structured individual interviews with open-ended questions
Risk factors of reproductive health issues
Time frame: Baseline
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions
Barriers to access to care for reproductive health issues
Time frame: Baseline
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions and group discussion (open-ended questions) with healthcare providers, stakeholders and policymakers
Facilitators to access to care for reproductive health issues
Time frame: Baseline
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions and group discussion (open-ended questions) with healthcare providers, stakeholders and policymakers
Service utilization for reproductive health issues
Time frame: Baseline
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions and group discussion (open-ended questions) with healthcare providers, stakeholders and policymakers
Career-related impact of reproductive health issues of female serving in the CAF
Time frame: Baseline
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions
Recommendations and support services for improving female reproductive care within the CAF
Time frame: Baseline
Assessed using a self-administered, pan-Canadian online questionnaire with multiple-choice response options and semi-structured individual interviews with open-ended questions and group discussion (open-ended questions) with healthcare providers, stakeholders and policymakers
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 May 2026.
- Official website of the Pelvic Health Research LaboratoryLink provided by the sponsor.
- Facebook page of the Pelvic Health Research LaboratoryLink provided by the sponsor.
- Instagram page of the Pelvic Health Research LaboratoryLink provided by the sponsor.
- Online pan-Canadian survey (part 1)Link provided by the sponsor.
- Individual participant dataSharing planned: No. Due to the nature of the participant population (active-duty military personnel and Veterans) and confidential information, individual data will not be shared. Only deanonymized and aggregated data will be shared with the scientific population and/or other organizations, upon request.
Related trials for Pregnancy
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mélanie Morin, PhD principal investigator
PT, PhD, Full professor, Researcher, Director of the Pelvic Health Research Laboratory, Canada Research Chair in Women's pelvic health, Faculty of Medicine and Health Sciences, University of Sherbrooke and Research Centre of the CHUS
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pregnancy and Pelvic Floor Dysfunction, run by Université de Sherbrooke at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 22 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chris M Edwards, PhD (1-888-463-1835 ext. 18439, labo.santepelvienne@USherbrooke.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Occurrence of female reproductive health issues (time frame: Baseline). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2026.